|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00071344 |
|
Date of registration:
|
20/10/2003 |
|
Primary sponsor: |
|
|
Public title:
|
Analysis of Brain Metastasis in Patients With Lung Cancer
|
|
Scientific title:
|
Analysis of Brain Metastasis in Patients With Lung Cancer |
|
Date of first enrolment:
|
October 2003 |
|
Target sample size:
|
78 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00071344 |
|
Study type:
|
Observational |
|
Study design:
|
N/A
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. A patient with a known or with radiographic evidence of a NSCLC neoplasm metastatic
to the brain, either SQ or AC.
2. Medically-indicated (diagnostic and/or therapeutic) brain tumor resection.
3. Informed consent from female patient, age 18 or older. In general, patients less
than 18 years of age rarely have NSCLC metastatic to the brain.
Exclusion Criteria:
1. Inability to provide informed consent prior to surgery.
2. Medical conditions that cannot be corrected prior to surgery that would be standard
contraindications for craniotomy (brain tumor patients).
Age minimum:
N/A
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Carcinoma, Non-Small -Cell Lung
|
|
Secondary ID(s)
|
|
04-N-0004
|
|
040004
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|